The Biological and Prognostic Implications of the Nicotinic Acetylcholine Receptor α3, α5, and α7 Subunits in Oral Squamous Cell Carcinoma
Related Experiment Video
Updated: Jan 12, 2026
Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons
Published on: June 24, 2015
Chi-Maw Lin1,2, Long-Wei Lin3, Tseng-Cheng Chen4
1Department of Otolaryngology, National Taiwan University Hospital, Yun-Lin Branch, Yun-Lin, Taiwan.
Background:
The divergent loop structures of nicotinic acetylcholine receptor (nAChR) α3, α5, and α7 subunits (encoded by CHRNA3, CHRNA5, and CHRNA7) are involved in kinase phosphorylation and signal transduction, potentially affecting oral squamous cell carcinoma (OSCC), the most common head and neck cancer (HNC). However, their specific roles in OSCC remain unclear.
Methods:
We integrated analyses of SCC-4 tongue cancer cells with CHRNA overexpression, immunohistochemistry of OSCC pathological specimens, and data from the cancer genome atlas (TCGA), DepMap, and Puram 2017 to assess CHRNA3, CHRNA5, and CHRNA7 in OSCC/HNC.
Results:
In OSCC, CHRNA3, CHRNA5, and CHRNA7 expression interacted with epithelial-mesenchymal transition (EMT) markers and correlated with invasive patterns. CHRNA3 reduced epithelial and enhanced mesenchymal traits, supporting EMT. CHRNA5 further promoted mesenchymal features, was linked to disseminated tumor patterns, and predicted poor prognosis. CHRNA7 enhanced both epithelial and mesenchymal markers, maintaining a hybrid EMT state. In HNC, bioinformatic analyses revealed that CHRNA3 preserved ion channel activity, CHRNA5 promoted DNA replication, reduced adhesion, suppressed antigen presentation, and induced hypomethylation and miRNA overexpression, while CHRNA7 promoted differentiation with variable effects on adhesion and antigen presentation. In DepMap HNC cell lines, high CHRNA3/CHRNA5 and low CHRNA7 expression were associated with resistance to most inhibitors. Epidermal growth factor receptor (EGFR) inhibitors were effective in CHRNA3/CHRNA7-high HNC, whereas cyclin-dependent kinase (CDK) inhibitors were effective in CHRNA5-high HNC.
Conclusion:
Differential expression of CHRNA3, CHRNA5, and CHRNA7 indicates different EMT states in OSCC/HNC, influencing proliferation, differentiation, cell adhesion, immune reactions, and treatment efficacy, and warrants further experimental validation.
Insights
Nicotinic acetylcholine receptor (nAChR) subunits CHRNA3, CHRNA5, and CHRNA7 influence oral squamous cell carcinoma (OSCC) progression and treatment response. Their differential expression impacts epithelial-mesenchymal transition (EMT) and drug sensitivity in head and neck cancer (HNC).
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Nicotinic acetylcholine receptor (nAChR) subunits (CHRNA3, CHRNA5, CHRNA7) are implicated in kinase phosphorylation and signal transduction.
- Their roles in oral squamous cell carcinoma (OSCC), a common head and neck cancer (HNC), are not fully understood.
- Divergent loop structures of these subunits may influence cancer cell behavior.
Purpose of the Study:
- To investigate the specific roles of CHRNA3, CHRNA5, and CHRNA7 in OSCC and HNC.
- To assess the correlation between CHRNA expression, epithelial-mesenchymal transition (EMT), and clinical outcomes.
- To evaluate the impact of CHRNA expression on treatment efficacy.
Main Methods:
- Integrated analysis of SCC-4 tongue cancer cells with CHRNA overexpression.
- Immunohistochemistry of OSCC pathological specimens.
- Bioinformatic analysis of The Cancer Genome Atlas (TCGA), DepMap, and Puram 2017 data for HNC.
Main Results:
- CHRNA3, CHRNA5, and CHRNA7 expression correlated with EMT markers and invasive patterns in OSCC.
- CHRNA3 promoted EMT, CHRNA5 predicted poor prognosis, and CHRNA7 maintained a hybrid EMT state.
- Bioinformatic analysis revealed distinct roles for each subunit in HNC, including effects on ion channel activity, DNA replication, adhesion, and immune response.
- High CHRNA3/CHRNA5 and low CHRNA7 expression were linked to resistance to most inhibitors in HNC cell lines.
- EGFR inhibitors were effective in CHRNA3/CHRNA7-high HNC, while CDK inhibitors were effective in CHRNA5-high HNC.
Conclusions:
- Differential expression of CHRNA3, CHRNA5, and CHRNA7 defines distinct EMT states in OSCC/HNC.
- These subunits influence key cancer processes: proliferation, differentiation, cell adhesion, and immune reactions.
- Understanding CHRNA subunit roles is crucial for predicting and improving treatment efficacy in HNC.
- Further experimental validation is warranted.
More Related Videos
Related Concept Videos
01:15Cholinergic Receptors: Nicotinic
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
01:25Cholinergic Receptors: Muscarinic
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
01:31Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...